A fossil record of zidovudine resistance in transmitted isolates of HIV-1

被引：17

作者：

Kuritzkes, DR ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO 80262 USA

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2001年 / 98卷 / 24期

关键词：

D O I：

10.1073/pnas.251559398

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：13485 / 13487

页数：3

共 27 条

[1] Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT):: Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase [J].

Arion, D ;

Kaushik, N ;

McCormick, S ;

Borkow, G ;

Parniak, MA .

BIOCHEMISTRY, 1998, 37 (45) :15908-15917

[2] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS [J].

BOUCHER, CAB ;

OSULLIVAN, E ;

MULDER, JW ;

RAMAUTARSING, C ;

KELLAM, P ;

DARBY, G ;

LANGE, JMA ;

GOUDSMIT, J ;

LARDER, BA .

JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :105-110

[3] Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase [J].

Boyer, PL ;

Sarafianos, SG ;

Arnold, E ;

Hughes, SH .

JOURNAL OF VIROLOGY, 2001, 75 (10) :4832-4842

[4] Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication [J].

Caliendo, AM ;

Savara, A ;

An, D ;

DeVore, K ;

Kaplan, JC ;

DAquila, RT .

JOURNAL OF VIROLOGY, 1996, 70 (04) :2146-2153

[5] Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine [J].

Coakley, EP ;

Gillis, JM ;

Hammer, SM .

AIDS, 2000, 14 (02) :F9-F15

[6] ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY [J].

DAQUILA, RT ;

JOHNSON, VA ;

WELLES, SL ;

JAPOUR, AJ ;

KURITZKES, DR ;

DEGRUTTOLA, V ;

REICHELDERFER, PS ;

COOMBS, RW ;

CRUMPACKER, CS ;

KAHN, JO ;

RICHMAN, DD .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) :401-408

[7] Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus [J].

de Ronde, A ;

van Dooren, M ;

van der Hoek, L ;

Bouwhuis, D ;

de Rooij, E ;

van Gemen, B ;

de Boer, R ;

Goudsmit, J .

JOURNAL OF VIROLOGY, 2001, 75 (02) :595-602

[8] Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].

Deeks, SG ;

Wrin, T ;

Liegler, T ;

Hoh, R ;

Hayden, M ;

Barbour, JD ;

Hellmann, NS ;

Petropoulos, CJ ;

McCune, JM ;

Hellerstein, MK ;

Grant, RM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480

[9] BRIEF REPORT - PRIMARY INFECTION WITH ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

ERICE, A ;

MAYERS, DL ;

STRIKE, DG ;

SANNERUD, KJ ;

MCCUTCHAN, FE ;

HENRY, K ;

BALFOUR, HH .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (16) :1163-1165

[10] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].

Finzi, D ;

Blankson, J ;

Siliciano, JD ;

Margolick, JB ;

Chadwick, K ;

Pierson, T ;

Smith, K ;

Lisziewicz, J ;

Lori, F ;

Flexner, C ;

Quinn, TC ;

Chaisson, RE ;

Rosenberg, E ;

Walker, B ;

Gange, S ;

Gallant, J ;

Siliciano, RF .

NATURE MEDICINE, 1999, 5 (05) :512-517

← 1 2 3 →